Skip to main content
SpringerLink
Log in

Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Pleiotropic actions of antitumor prostaglandins (PGs) on tumor cells are reviewed including our preclinical results focused on human ovarian cancer. Regarding inhibition of cell proliferation, antitumor PGs exerts its action as a G1 blocking agent. The cyclopentenone PGs inhibit myc oncogene expression while inhibiting the cell cycle progression and results in apoptotic cell death and growth inhibition. Cyclopentenone PGs inhibit growth of various tumors transplanted to mice or nude mice and show adjuvant effects to cis-diamminedichloroplatinum(II) (CDDP). In order to elucidate a role of antitimor PGs in immune systems, relevance of effects on tumor growth with those on the immune systems are also discussed with our results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fukushima M: Prostaglandin J2-anti-tumor and anti-viral activities and the mechanisms involved. Eicosamoids 3: 189–199, 1990

    Google Scholar 

  2. Fukushima M: Biological activities and mechanisms of action of PGJ2 and related compounds: an update Prostagl Lenkotr Essen Fatty Acids 47: 1–12, 1992

  3. Sasaki H, Fukushima M: Prostaglandins in the treatment of cancer. Anti-Cancer Drugs 5: in press, 1994

  4. Hughes-Fulford M, Wu J, Kato T, Fukushima M: Inhibition of DNA synthesis and cell cycle by prostaglandins independent of cyclic AMP. Adv Prostaglandin Thromboxane Leukotrien Res 15: 401–404, 1985

    Google Scholar 

  5. Hughes-Fulford M, Fukushima M: Control of cell cycle by metabolites of prostaglandin D2 through non-cAMP mediated mechanism. Exp Clin Endocrinol (Life Sci Adv) 12: 57–64, 1993

    Google Scholar 

  6. Narumiya S, Fukushima M: Site and mechanism of growth inhibition by prostaglandins I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J Pharmacol Exp Ther 239: 500–505, 1986

    Google Scholar 

  7. Narumiya S, Ohno K, Fujiwara M, Fukushima M: Site and mechanism of growth inhibition by prostaglandins II. Temperature-dependent transfer of cyclopentenous prostaglandin to nuclei. J Pharmacol Exp Ther 239: 506–511, 1986

    Google Scholar 

  8. Narumiya S, Ohno K, Fukushima M, Fujiwara M: Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and Λ12-prostaglandin J2 in nuclei. J Pharmacol Exp Ther 242: 306–311, 1987

    Google Scholar 

  9. Bhuyan BK, Adams EG, Badiner GJ, Li LH, Barden K: Cell cycle effects of prostaglandins A1, A2 and D2 in human and murine melanoma cells in culture. Cancer Res 46: 1688–1693, 1986

    Google Scholar 

  10. Ohno K, Sakai T, Fukushima M, Narumiya S, Fujiwara M: Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1 enriched HeLa S3 cells. J Pharmacol Exp Ther 245: 294–298, 1988

    Google Scholar 

  11. Ishioka C, Kanamaru R, Sato T, Dei T, Konishi Y, Asamura M, Wakui A: Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. Cancer Res 48: 2813–2818, 1988

    Google Scholar 

  12. Marui N, Sakai T, Hosokawa N, Yashida M, Aoike A, Kawai K, Nishino H, Fukushima M: N-myc suppression and cell cycle arrest at G1 phase by prostaglandins. FEBS Lett 270: 15–18, 1990

    Google Scholar 

  13. Kim I-K, Lec J-H, Sohn H-W, Kim H-S, Kim S-H: Prostaglandin A2 and Λ12 prostaglandin J2 induce apoptosis in L1210 cells. FEBS Lett 321: 209–214, 1993

    Google Scholar 

  14. Kikuchi Y, Iwano I, Kato K: Effect of calmodulin antagonists on human ovarian cancer cell proliferationin vitro. Biochem Biophys Res Commun 123: 385–392, 1984

    Google Scholar 

  15. Honn KV, Marnett LJ: Requirement of a reactive α, β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by ‘A’ series prostaglandins. Biochem Biophys Res Commun 129: 34–40, 1985

    Google Scholar 

  16. Fukushima M, Kato T, Narumiya S, Mizushima Y, Sasaki H, Terashima Y, Nishiyama Y, Santoro MG: Prostaglandin A and J: antitumor and antiviral prostaglandins. Adv Prostaglandin Thromboxane Leukotrien Res 19: 415–418, 1989

    Google Scholar 

  17. Noyori R, Suzuki M: Organic synthesis of prostaglandins: Advancing biology. Science 259: 44–45, 1993

    Google Scholar 

  18. Atsmon J, Freeman ML, Meredith MJ, Sweetman BJ, Roberts LJ II: Conjugation of 9-deoxy-Λ9, Λ12 (E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. Cancer Res 50: 1879–18856, 1990

    Google Scholar 

  19. Kikuchi Y, Kizawa I, Oomori K, Muyauchi M, Kita T, Sugita M, Tenjin Y, Kato K: Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation. Cancer Res 47: 592–596, 1987

    Google Scholar 

  20. Kikuchi Y, Hirata J, Kita T, Imaizumi E, Tode T, Nagta I: Enhancement of antiproliferative effect of cis-diammined-ichloropltinum(II) by clomiphene and tamoxifen in human ovarian cancer cells. Gynecol Oncol 49: 365–372, 1993

    Google Scholar 

  21. Hirata J, Kikuchi Y, Kita T, Imaizumi E, Tode T, Ishii K, Kudoh K, Nagata I: Modulation of sensitivity of human ovarian cancer cells to cis-diammine-dichloroplatinum(II) by 12-0-tetradecanoylphorbol-13-acetate and D, L-buthionine-S, R-sulphoximine. Int J Cancer 55: 521–527, 1993

    Google Scholar 

  22. Kato T, Fukushima M, Kurozumi S, Noyori R: Antitumor activity of Λ7-prostaglandin A1 and Λ12-prostaglandin J2 in vitro andin vivo. Cancer Res 46: 3538–3542, 1986

    Google Scholar 

  23. Kikuchi Y, Miyauchi M, Oomori K, Kita T, Kitazawa I, Kato K: Inhibition of human ovarian cancer cell growthin vitro and in nude mice by prostaglandin D2. Cancer Res 46: 3364–3366, 1986

    Google Scholar 

  24. Kikuchi Y, Miyauchi M, Iwano I, Kita T, Oomori K, Kizawa I: Adjuvant effects of prostaglandin D2 to cisplatin on human ovarian cancer cell growth in nude mice. Eur J Cancer Clin Oncol 24: 1829–1833, 1988

    Google Scholar 

  25. Narumiya S, Fukushima M: Λ12-prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. Biochem Biophys Res Commun 127: 739–747, 1985

    Google Scholar 

  26. Hirata Y, Hayashi H, Ito S, Kikawa Y, Ishibashi M, Sudo M, Miyazaki H, Fukushima M, Narumiya S, Hayaishi O: Occurrence of 9-deoxy-Λ9. Λ12-13,14-dihydroprostaglandin D2 in human urine. J Biol Chem 263: 16619–16625, 1988

    Google Scholar 

  27. Kikuchi Y, Kita T, Miyauchi M, Hirata J, Sasa H, Nagata I, Fukushima M: Adjuvant effects of antiproliferative prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells. J Cancer Res Clin Oncol 118: 453–457, 1992

    Google Scholar 

  28. Sasaki H, Takada K, Terashima Y, Ekimoto H, Takahashi K, Tsuruo T, Fukushima M: Human ovarian cancer cell lines resistant to cisplatin, doxorubicine and L-phenylalanine mustard are sensitive to Λ7-prostaglandin A1 and Λ12-prostaglandin J2. Gynecol Oncol 41: 36–40, 1990

    Google Scholar 

  29. Fukushima S, Takeuchi Y, Nakano M, Kita T, Kikuchi Y, Fukushima M: Λ7-PGA1 lipid microsphere-pharmaceutical properties and preclinical evaluations. In: Yasugi T, Nakamura H, Soma M (eds) Advances in polyunsaturated fatty acids res. Excerpta Medica, Tokyo, 1993, pp 67–70

    Google Scholar 

  30. Fukushima M, Sasaki H, Fukushima S: Prostaglandin J2 and related compound made of action in G1 arrest and preclinical results. In: Goetzl EJ, Rola-Pleszizynski M (eds) Cellular generation transport and effects of eicosanoids: Biological roles and pharmacological intervention. Acad Sci, New York, 1994, in press

    Google Scholar 

  31. Stobo JD, Kennedy MS, Goldyne ME: Prostaglandin E modulation of the mitogen response of human T cells. Differential response of T-cell subpopulations. J Clin Invest 64: 1188–1195, 1979

    Google Scholar 

  32. Leung KH, Mihich E: Prostaglandin modulation of development of cell-mediated immunity in culture. Nature 288: 597–600, 1980

    Google Scholar 

  33. Goodwin JS, Webb DR: Review; regulation of the immune response by prostaglandins. Clin Immunol Immunopathol 15: 106–122, 1980

    Google Scholar 

  34. Ferraris VA, DeRubertis FR: Release of prostaglandin by mitogen and antigen-stimulated leukocytes in culture. J Clin Invest 54: 378–386, 1974

    Google Scholar 

  35. Humes JC, Bonney RJ, Pelus L, Dahlgren ME, Sadowski SJ, Kuehl FA Jr, Davis P: Macrophages synthesize and release prostaglandins in response to inflammatory stimuli. Nature 269: 149–151, 1977

    Google Scholar 

  36. Jaffe BM: Prostaglandins and cancer: an update. Prostaglandins 6: 453–461, 1974

    Google Scholar 

  37. Easty GC, Easty DM: Prostaglandins and cancer. Cancer Treat Rev 3: 217–225, 1976

    Google Scholar 

  38. Kikuchi Y, Kita T, Hirata J, Kuki E, Nagata I, Fukushima M: Modulation of human lymphocytes response to phytohemagglutinin by antineoplastic prostaglandins. Int J Immunopharmac 14: 105–110, 1992

    Google Scholar 

  39. Petrini B, Wasserman J, Hammarstrom S, Blomgren H, Vedin I: Modulation of lymphocyte and monocyte responsesin vitro by 9-deoxy-Λ9-prostaglandin D2 and 9-deoxy-Λ9-Λ12-prostaglandin D2. Int Archs Allergy Appl Immunol 87: 388–391, 1988

    Google Scholar 

  40. Wasserman J, Hammarstrom S, Petrini B, Blimgren H, von-Stedingk L-V, Vedin I: Effects of some prostaglandins and leukotriens on lymphocytes, monocytes and their activityin vitro. Int Archs Allergy Appl Immunol 83: 39–43, 1987

    Google Scholar 

  41. Webb DR, Nowowiejski I: Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity. Cell Immunol 41: 72–85, 1978

    Google Scholar 

  42. Favalli C, Garaci E, Etheredge E, Santoro MG, Jaffe BM: Influence of PGE on the immune response in melanoma bearing mice. J Immunol 125: 897–902, 1980

    Google Scholar 

  43. Mertin J, Stackpoole A: Anti-PGE antibodies inhibitin vivo development of cell-mediated immunity. Nature 294: 456–458, 1981

    Google Scholar 

  44. Smith JW, Steiner AL, Parker CW: Human lymphocyte metabolism. Effect of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest 50: 442–448, 1971

    Google Scholar 

  45. Goodwin JS, Bankhurst AD, Messner RP: Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 146: 1719–1734, 1977

    Google Scholar 

  46. Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, Williams RC Jr: Prostaglandin-producing suppressor cells in Hodgkin's disease. New Engl J Med 297: 963–968, 1977

    Google Scholar 

  47. Goodwin JS, Messner RP, Peake GT: Prostaglandin suppression of mitogen-stimulated lymphocytesin vitro. Changes with mitogen dose and preincubation. J Clin Invest 62: 753–760, 1978

    Google Scholar 

  48. Hacker-Shashin B, Droege W: Augmentation of cytotoxic response by prostaglandin E2. Cell Immunol 91: 43–51, 1985

    Google Scholar 

  49. Wolf M, Droege W: Inhibition of cytotoxic responses by prostaglandin E2 in the presence of interleukin 2. Cell Immunol 72: 286–293, 1982

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, National Defense Medical College, Namiki 3-2, 359, Tokorozawa, Saitama, Japan

    Yoshihiro Kikuchi, Tsunekazu Kita & Junko Hirata

  2. Department of Internal Medecine, Aichi Cancer Center, Chikusa-ku, 464, Nagoya, Japan

    Masanori Fukushima

Authors
  1. Yoshihiro Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tsunekazu Kita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junko Hirata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masanori Fukushima
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kikuchi, Y., Kita, T., Hirata, J. et al. Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells. Cancer Metast Rev 13, 309–315 (1994). https://doi.org/10.1007/BF00666101

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00666101

Key words

Search

Navigation